[Application of serum LDH and MDH activities for controlling the course of radiotherapy of breast and uterine cancer. Preliminary communication].
D001943:Breast Neoplasms / Q000097:blood / Q000201:enzymology / Q000532:radiotherapy*; D003037:Cobalt Radioisotopes; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008291:Malate Dehydrogenase / Q000097:blood*; D011867:Radioisotope Teletherapy; D014594:Uterine Neoplasms / Q000097:blood / Q000201:enzymology / Q000532:radiotherapy*
D003037:Cobalt Radioisotopes; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase
Die Verwendung der Serumaktivität von LDH und MDH zur Verlaufskontrolle der Strahlentherapie von Mamma- und Uterus-Karzinomen. Vorläufige Mitteilung